Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura.

Ellithy HN, Ahmed SH, Shahin GH, Matter MM, Talatt M.

Hematology. 2018 Apr;23(3):169-174. doi: 10.1080/10245332.2017.1371479. Epub 2017 Aug 31.

PMID:
28856973
2.

[Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance].

Zhu Y, Zhuang Y, Yang GH, Qiang XF, Yang L, Shen YF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):135-9. doi: 10.7534/j.issn.1009-2137.2013.01.028. Chinese.

PMID:
23484707
3.

FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.

Eyada TK, Farawela HM, Khorshied MM, Shaheen IA, Selim NM, Khalifa IA.

Blood Coagul Fibrinolysis. 2012 Jan;23(1):64-8. doi: 10.1097/MBC.0b013e32834ddf2f.

PMID:
22123287
4.

Fcγ receptor gene polymorphisms in childhood immune thrombocytopenic purpura.

Amorim DM, Silveira Vda S, Scrideli CA, Queiroz RG, Tone LG.

J Pediatr Hematol Oncol. 2012 Jul;34(5):349-52. doi: 10.1097/MPH.0b013e3182580908.

PMID:
22713706
5.

Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.

Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB.

Br J Haematol. 2012 Aug;158(4):539-47. doi: 10.1111/j.1365-2141.2012.09184.x. Epub 2012 Jul 6.

PMID:
22775462
6.

Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.

Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T, Pehlıvan S.

Platelets. 2011;22(8):588-95. doi: 10.3109/09537104.2011.577255. Epub 2011 May 19.

PMID:
21591983
7.

Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura.

Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA.

Br J Haematol. 2003 Jan;120(1):135-41.

PMID:
12492589
8.

Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia.

Burkhardt B, Yavuz D, Zimmermann M, Schieferstein J, Kabickova E, Attarbaschi A, Lisfeld J, Reiter A, Makarova O, Worch J, Bonn BR, Damm-Welk C.

Ann Hematol. 2016 Sep;95(9):1503-12. doi: 10.1007/s00277-016-2731-x. Epub 2016 Jul 4.

PMID:
27376362
9.

FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.

Papagianni A, Economou M, Tragiannidis A, Karatza E, Samarah F, Gombakis N, Athanassiadou-Piperopoulou F, Vavatsi-Christaki N, Athanassiou-Metaxa M.

Blood Coagul Fibrinolysis. 2013 Jan;24(1):35-9. doi: 10.1097/MBC.0b013e328359bc3b.

PMID:
23249566
10.

Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura.

Fujimoto TT, Inoue M, Shimomura T, Fujimura K.

Br J Haematol. 2001 Oct;115(1):125-30.

PMID:
11722422
11.

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

Bibeau F, Lopez-Crapez E, Di Fiore F, Thezenas S, Ychou M, Blanchard F, Lamy A, Penault-Llorca F, Frébourg T, Michel P, Sabourin JC, Boissière-Michot F.

J Clin Oncol. 2009 Mar 1;27(7):1122-9. doi: 10.1200/JCO.2008.18.0463. Epub 2009 Jan 21.

PMID:
19164213
12.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.

Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.

Am J Hematol. 2005 Apr;78(4):275-80.

13.

Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.

Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.

Blood Coagul Fibrinolysis. 2016 Jun;27(4):431-5. doi: 10.1097/MBC.0000000000000488.

PMID:
26656905
14.

The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).

Basciano PA, Bussel J, Hafeez Z, Christos PJ, Giannakakou P.

Br J Haematol. 2013 Jan;160(2):237-43. doi: 10.1111/bjh.12124. Epub 2012 Nov 15.

15.

Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.

Hatjiharissi E, Hansen M, Santos DD, Xu L, Leleu X, Dimmock EW, Ho AW, Hunter ZR, Branagan AR, Patterson CJ, Kortsaris A, Verselis S, Fox E, Treon SP.

Clin Lymphoma Myeloma. 2007 Jan;7(4):286-90.

PMID:
17324336
16.

Correlation of FcγRIIIa Polymorphisms to the Response of Rituximab in Thai Patients with Diffuse Large B-Cell Lymphoma.

Angsirisak N, Wittayalertpanya S, Limpanasithikul W, Bunworasate U, Owattanapanich D.

J Med Assoc Thai. 2015 Dec;98(12):1215-21.

PMID:
27004307
17.

FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.

Lejeune J, Piègu B, Gouilleux-Gruart V, Ohresser M, Watier H, Thibault G.

MAbs. 2012 Nov-Dec;4(6):784-7. doi: 10.4161/mabs.22287. Epub 2012 Oct 2.

18.
19.

FCGR2A rs1801274 polymorphism is associated with risk of childhood-onset idiopathic (immune) thrombocytopenic purpura: evidence from a meta-analysis.

Wang D, Hu SL, Cheng XL, Yang JY.

Thromb Res. 2014 Dec;134(6):1323-7. Epub 2014 Oct 13. Review.

PMID:
25457587
20.

Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori.

Suzuki T, Matsushima M, Shirakura K, Koike J, Masui A, Takagi A, Shirasugi Y, Ogawa Y, Shirai T, Mine T.

Digestion. 2008;77(2):73-8. doi: 10.1159/000121392. Epub 2008 Mar 20.

PMID:
18354254

Supplemental Content

Support Center